Figure 4.Increase in EGFR-Thr790Met prevalence at the time of disease progression according to different testing strategies. A: Cobas®, B: ddPCR—peripheral blood, C: ddPCR—peripheral blood + ddPCR—other body fluids and D: Strategy C + second tissue biopsies. Prevalence obtained with each...
All SectionsBiopharmaceuticalsMedicinal ChemistryNatural ProductsPharmaceutical TechnologyPharmacologyRadiopharmaceutical SciencesGeneral All Special IssuesActive Pharmaceutical IngredientsAdvances in Drug DesignAdvances in Natural Products and Their Derivatives for Metabolic and Chronic Inflammatory Disease Therapy, 2nd Editi...